| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:05:00 UTC |
|---|
| Update date | 2020-02-24 19:10:23 UTC |
|---|
| Primary ID | FDB001514 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | 1,5-Dicaffeoylquinic acid |
|---|
| Description | 1,5-Dicaffeoylquinic acid, also known as cynarin, belongs to the class of organic compounds known as quinic acids and derivatives. Quinic acids and derivatives are compounds containing a quinic acid moiety (or a derivative thereof), which is a cyclitol made up of a cyclohexane ring that bears four hydroxyl groups at positions 1,3.4, and 5, as well as a carboxylic acid at position 1. 1,5-Dicaffeoylquinic acid has been detected, but not quantified in, a few different foods, such as cardoons (Cynara cardunculus), fennels (Foeniculum vulgare), and globe artichokes (Cynara scolymus). This could make 1,5-dicaffeoylquinic acid a potential biomarker for the consumption of these foods. Based on a literature review a significant number of articles have been published on 1,5-Dicaffeoylquinic acid. |
|---|
| CAS Number | 30964-13-7 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| Cynarin | ChEBI | | 1,5-Dicaffeoylquinate | Generator | | 1,5-Di-O-caffeoylquinic acid | HMDB | | Cinarine | HMDB | | Cynarine | HMDB | | 1,3-Dicaffeoylquinate | Generator | | Cinarin | MeSH | | Cynarix | MeSH | | Listrocol | MeSH | | Phemocil | MeSH | | 1,5-Dicaffeoylquinic acid | MeSH | | Nivellipid | MeSH | | Cinarina | MeSH | | Cynarin, (1alpha,3alpha,4alpha,5beta)-isomer | MeSH | | 1-Carboxy-4,5-dihydroxy-1,3-cyclohexylenebis-(3,4-dihydroxycinnamate) | MeSH | | Cynarex | MeSH | | Listricol | MeSH |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C25H24O12 |
|---|
| IUPAC name | (1R,3R,4S,5R)-1,3-bis({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4,5-dihydroxycyclohexane-1-carboxylic acid |
|---|
| InChI Identifier | InChI=1S/C25H24O12/c26-15-5-1-13(9-17(15)28)3-7-21(31)36-20-12-25(24(34)35,11-19(30)23(20)33)37-22(32)8-4-14-2-6-16(27)18(29)10-14/h1-10,19-20,23,26-30,33H,11-12H2,(H,34,35)/b7-3+,8-4+/t19-,20-,23+,25-/m1/s1 |
|---|
| InChI Key | YDDUMTOHNYZQPO-RVXRWRFUSA-N |
|---|
| Isomeric SMILES | O[C@@H]1C[C@](C[C@@H](OC(=O)\C=C\C2=CC=C(O)C(O)=C2)[C@H]1O)(OC(=O)\C=C\C1=CC=C(O)C(O)=C1)C(O)=O |
|---|
| Average Molecular Weight | 516.4509 |
|---|
| Monoisotopic Molecular Weight | 516.126776232 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as quinic acids and derivatives. Quinic acids and derivatives are compounds containing a quinic acid moiety (or a derivative thereof), which is a cyclitol made up of a cyclohexane ring that bears four hydroxyl groups at positions 1,3.4, And 5, as well as a carboxylic acid at position 1. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Alcohols and polyols |
|---|
| Direct Parent | Quinic acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Quinic acid
- Cinnamic acid or derivatives
- Coumaric acid or derivatives
- Cinnamic acid ester
- Hydroxycinnamic acid or derivatives
- Tricarboxylic acid or derivatives
- Catechol
- Styrene
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Cyclohexanol
- Phenol
- Fatty acid ester
- Monocyclic benzene moiety
- Fatty acyl
- Benzenoid
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- 1,2-diol
- Carboxylic acid ester
- Secondary alcohol
- Carboxylic acid
- Carboxylic acid derivative
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Not Available | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | Not Available | |
|---|
| Melting Point | Not Available | |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | 1,5-Dicaffeoylquinic acid, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-03dl-8592200000-bf336f61df2036277f1e | Spectrum | | Predicted GC-MS | 1,5-Dicaffeoylquinic acid, 2 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-000i-1945103000-92e839d6fb722a93bc0b | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - 30V, Positive | splash10-03di-0900000000-6d52c792575df3ea7dbb | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-03dj-0903430000-a18151ab89b9b110f44c | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 40V, Positive | splash10-03di-0900000000-54c323557c7357c35524 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 20V, Positive | splash10-03di-0900000000-1644d35ec69323eaa8a0 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 20V, Negative | splash10-0uxr-0209050000-0f31371ea7d416714594 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 30V, Negative | splash10-0ufu-0904000000-2f7077d091afe3599b4f | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Negative | splash10-014i-0000090000-ae962c3fd60e067196d5 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 50V, Positive | splash10-03di-0900000000-51963ffb91ade18e9c29 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 50V, Negative | splash10-002o-0900000000-f36e70eb02306a828238 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 40V, Negative | splash10-002f-0900000000-cf7b0f27cf2a176d6f0e | 2021-09-20 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-02tj-0709640000-93a124ca1ee347170ee5 | 2017-09-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000i-0907300000-c1b3f5ea82ad93560c14 | 2017-09-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-024u-0902200000-aeb4454f422056c292f4 | 2017-09-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0gb9-0419580000-83812afaf2e5ea383af6 | 2017-09-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0r99-0729300000-eba47ae47a52917059ab | 2017-09-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-06vi-0915000000-c68bce1e5294ad4dca56 | 2017-09-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03xs-0905430000-e56ccef26012aa1a2752 | 2021-09-22 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-0901100000-039532264a956bcc1b1c | 2021-09-22 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0409-1900200000-b1fdfb3ba1ae534a6395 | 2021-09-22 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-014i-0200090000-b7b5c2bba6df98a0de34 | 2021-09-23 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-00kr-0948000000-1aadf69ab983a16d0ff7 | 2021-09-23 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-000i-0921100000-a6f3439fcc24a437a7db | 2021-09-23 | View Spectrum |
|
|---|
| NMR | Not Available |
|---|
| External Links |
|---|
| ChemSpider ID | 4445082 |
|---|
| ChEMBL ID | CHEMBL487258 |
|---|
| KEGG Compound ID | C10445 |
|---|
| Pubchem Compound ID | 5281769 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| Phenol-Explorer ID | 528 |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB30093 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | Not Available |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | CYNARIN |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00002733 |
|---|
| HET ID | Not Available |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Cynarine |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anti bacterial | 33282 | An agent that inhibits the growth of or destroys bacteria, playing a crucial role in preventing and treating infections. Therapeutically, it is used to combat bacterial infections, with key medical applications including treating pneumonia, tuberculosis, and skin infections, as well as preventing surgical site infections and sepsis. | DUKE | | Anti dyspeptic | 52217 | An agent that alleviates indigestion and digestive discomfort, reducing symptoms of dyspepsia. It plays a biological role in regulating stomach acid and digestive enzyme activity. Therapeutically, it is used to manage gastrointestinal disorders, such as irritable bowel syndrome, and to relieve nausea, bloating, and abdominal pain. Key medical uses include treating gastroesophageal reflux disease and peptic ulcers. | DUKE | | Anti lipolytic | | An agent that prevents the breakdown of lipids, playing a biological role in regulating fat metabolism. Therapeutically, it is used to manage conditions like hypertriglyceridemia and diabetic ketoacidosis, with key medical applications in lipid disorders and cardiovascular disease prevention. | DUKE | | Anti-staphylococcic | 33282 | An agent that combats Staphylococcus infections, playing a crucial role in preventing bacterial growth. Therapeutically, it is used to treat skin and soft tissue infections, respiratory tract infections, and bloodstream infections. Key medical uses include treating methicillin-resistant Staphylococcus aureus (MRSA) and other staphylococcal infections, reducing the risk of infection and promoting wound healing. | DUKE | | Anti-streptococcic | 33282 | An agent that targets and combats Streptococcus bacteria, reducing infection and inflammation. Therapeutically, it is used to treat streptococcal infections, such as strep throat and skin infections, and to prevent complications like rheumatic fever. | DUKE | | Anti sunburn | 52217 | An agent that protects the skin from sun damage, reducing inflammation and preventing burns. Its biological role is to absorb or reflect UV radiation, therapeutic applications include preventing skin cancer and photoaging, and key medical uses include treating sunburn, premature aging, and skin discoloration. | DUKE | | Cholagogue | | An agent that stimulates the release of bile from the gallbladder, promoting digestion and relieving bile duct issues. Therapeutically, it aids in treating gallstones, jaundice, and liver disorders, while also supporting digestive health. | DUKE | | Choleretic | | An agent that increases bile production and secretion from the liver, enhancing digestion and fat absorption. Therapeutically, it's used to treat gallstones, liver disease, and indigestion, promoting healthy bile flow and liver function. | DUKE | | Cholesterolytic | | An enzyme that breaks down cholesterol, playing a key biological role in lipid metabolism. Therapeutically, it has applications in managing hypercholesterolemia and atherosclerosis, with potential uses in cardiovascular disease prevention and treatment. | DUKE | | Central nervous system active | 35470 | An agent that affects brain and spinal cord function, influencing mood, cognition, and physical responses. Therapeutically, it's used to manage neurological and psychiatric disorders, such as depression, anxiety, and insomnia, by modulating neurotransmitter activity and neural pathways. | DUKE | | Collagen-sparing | | An agent that preserves collagen, reducing its degradation and promoting tissue repair. It plays a biological role in maintaining skin and joint health. Therapeutically, it has applications in wound healing, osteoarthritis, and skin rejuvenation, with key medical uses in dermatology and orthopedics to prevent tissue damage and promote regeneration. | DUKE | | Cytoprotective | | An agent that protects cells from damage caused by noxious chemicals, oxidative stress, or other harmful stimuli, playing a key role in preventing cell injury and death. Therapeutically, cytoprotectives are used to treat conditions such as gastroesophageal reflux disease, mucositis, and neurodegenerative disorders, with applications in oncology, gastroenterology, and neurology. | DUKE | | Diuretic | 35498 | An agent that increases urine production, helping remove excess fluids and salts from the body. It plays a key biological role in regulating fluid balance and blood pressure. Therapeutically, diuretics are used to treat conditions such as hypertension, edema, and heart failure, helping reduce swelling and lower blood pressure. | DUKE | | Hepatoprotective | 62868 | An agent that protects the liver from damage, promoting liver health and function. It plays a biological role in reducing oxidative stress and inflammation, and has therapeutic applications in managing liver diseases, such as hepatitis and cirrhosis, and key medical uses in treating drug-induced liver injury and toxicities. | DUKE | | Hepatoregenerative | 62868 | An agent that promotes liver regeneration and repair, supporting the biological role of liver tissue restoration. It has therapeutic applications in treating liver diseases, such as cirrhosis and hepatitis, and key medical uses include enhancing liver function and reducing liver damage. | DUKE | | Hepatotonic | | An agent that tones and strengthens the liver, promoting liver health and function. It is used therapeutically to enhance liver regeneration, detoxification, and overall well-being, commonly used in managing liver diseases, such as hepatitis and cirrhosis, and supporting recovery from liver damage. | DUKE | | Hyperemic | | An agent that increases blood flow to a body part, promoting engorgement. It plays a biological role in wound healing and inflammation. Therapeutically, hyperemics are used to treat conditions like erectile dysfunction and poor circulation. Key medical uses include enhancing blood flow to targeted areas, reducing ischemia, and promoting tissue oxygenation. | DUKE | | Hypocholesterolemic | | An agent that lowers cholesterol levels in the blood, playing a crucial role in preventing cardiovascular disease. Therapeutically, it is used to manage hyperlipidemia and reduce the risk of heart disease, with key medical applications including the treatment of high cholesterol, atherosclerosis, and coronary artery disease. | DUKE | | Hypolipidemic | | An agent that lowers lipid levels, treating hyperlipidemias by reducing cholesterol and triglyceride production, with therapeutic applications in managing cardiovascular disease, atherosclerosis, and stroke, commonly used to prevent heart attacks and improve overall cardiovascular health. | DUKE | | Hypotriglyceridemic | | An agent that lowers triglyceride levels in the blood, playing a role in lipid metabolism. Therapeutically, it helps manage hypertriglyceridemia, reducing the risk of cardiovascular disease and pancreatitis, with key medical uses in treating dyslipidemia and preventing atherosclerosis. | DUKE | | Lipolytic | | An agent that stimulates hydrolysis of fats into fatty acids and glycerol, playing a key biological role in fat metabolism. Therapeutically, lipolytics have applications in managing obesity and hypertriglyceridemia, with medical uses including weight loss and improving lipid profiles. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE | | Sweetener | 50505 | A substance that adds sweetness to food and beverages, often used as a sugar substitute. Its biological role is to stimulate taste receptors, while its therapeutic applications include managing calorie intake and blood sugar levels. Key medical uses include treating diabetes and obesity, as well as reducing tooth decay risk. | DUKE |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181. — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004).
|
|---|